Aging is a natural phenomenon peculiar to all living beings. It is associated with several dynamic changes that occur in the behavioral, biological, environmental, physiological, psychological and social processes over time.
As per the World Health Organization (WHO), 1 in 6 people in the world will be aged more than 60 years by 2030. Further, the elderly population is likely to be 1.4 billion by 2030 and will grow to 2.1 billion by 2050, with 80% of the seniors living in developing countries.
Aging affects the body through multiple levels, including cellular, metabolic, immune, hepatic, hormonal and nephrotic.
Get Detailed Report: https://www.rootsanalysis.com/reports/anti-aging-therapeutics-market.html
CAUSES OF AGING
There is complex interplay of several factors that cause an organism to age. Certain factors contribute to the external or visible signs of aging whereas others lead to the aging of internal systems. However, in both ways, the overall bodily functions are hampered, gradually resulting in loss of physical and mental capacity, as well as increased risk of vulnerability, diseases and mortality.
Presently, research on the aging biology is focused on identifying the various cellular and molecular markers that contribute to aging.
Anti-aging therapeutics is a promising field of medical science that focuses on slowing down the aging process by different approaches. These regenerative drugs are designed to improve the organ function, repair the damaged tissues, optimize bodily systems and enhance quality of life.
Aging is a driving factor for a wide range of diseases in an individual. Most of the age-related changes are common, including dementia, high blood pressure, joint pain, minor loss in sensory processes (hearing and vision) and weakened immune system. Further, the chronic indications affecting senior populations include chronic obstructive pulmonary disease, cardiovascular diseases, cancer, chronic kidney disease and diabetes.
Request for Customization @ https://www.rootsanalysis.com/reports/anti-aging-therapeutics-market/request-customization.html
The identification and development of therapeutics that extend the longevity of a person by targeting the biological drivers of aging have presently become a significant topic for research. Various candidates are being investigated in the preclinical and clinical stages of development by research institutes and start-ups, across the world.
Having realized the opportunity associated with this lucrative domain, several stakeholders, have garnered huge amounts through different funding rounds. Further, the market for anti-aging therapeutics is likely to evolve at a healthy pace, over the next decade. Several novel drugs and therapeutics will be introduced utilizing stem cells (embryonic and adult) and targeted delivery systems.
Key Questions Answered
- Who are the leading players engaged in the development of anti-aging therapeutics?
- What types of partnership models are commonly adopted by industry stakeholders engaged in this industry?
- Who are the key investors in the anti-aging therapeutics domain?
- How is the intellectual property landscape in this field likely to evolve in the foreseen future?
- What is the evolving trend of publications focused on anti-aging therapeutics?
- What are the key value drivers that are likely to influence the evolution of this upcoming market?
- How is the current and future market opportunity likely to be distributed across key market segments?
Read Our Latest Blogs:
About Roots Analysis
Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector.
Company Name: Roots Analysis
Contact Person: Ben Johnson
Email: Send Email
Phone: +1 (415) 800 3415, +44 (122) 391 1091
Country: United Kingdom